ES2140658T3 - Sistemas terapeuticos transdermicos que contienen esteroides sexuales. - Google Patents
Sistemas terapeuticos transdermicos que contienen esteroides sexuales.Info
- Publication number
- ES2140658T3 ES2140658T3 ES95908925T ES95908925T ES2140658T3 ES 2140658 T3 ES2140658 T3 ES 2140658T3 ES 95908925 T ES95908925 T ES 95908925T ES 95908925 T ES95908925 T ES 95908925T ES 2140658 T3 ES2140658 T3 ES 2140658T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- therapeutic systems
- systems containing
- contain
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Abstract
SE DESCRIBEN SISTEMAS TERAPEUTICOS TRANSDERMICOS CONTENIENDO ESTEROIDES SEXUALES, Y OPCIONALMENTE FAVORECEDORES DE LA PENETRACION E INHIBIDORES DE LA CRISTALIZACION, QUE SE CARACTERIZAN PORQUE CONTIENEN ISOSORBIDO DE DIMETILO, CON EXCEPCION DE LOS SISTEMAS QUE CONTENGAN FASES EN GEL NO FLUIDAS LLEVANDO EL PRINCIPIO ACTIVO O 3-CETO-DESORGESTREL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4405898A DE4405898A1 (de) | 1994-02-18 | 1994-02-18 | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2140658T3 true ES2140658T3 (es) | 2000-03-01 |
Family
ID=6511044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95908925T Expired - Lifetime ES2140658T3 (es) | 1994-02-18 | 1995-02-09 | Sistemas terapeuticos transdermicos que contienen esteroides sexuales. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5904931A (es) |
EP (1) | EP0744944B1 (es) |
JP (1) | JPH09508912A (es) |
KR (1) | KR100392435B1 (es) |
AT (1) | ATE186213T1 (es) |
AU (1) | AU1706695A (es) |
CA (1) | CA2183543C (es) |
DE (2) | DE4405898A1 (es) |
DK (1) | DK0744944T3 (es) |
ES (1) | ES2140658T3 (es) |
GR (1) | GR3032512T3 (es) |
HU (1) | HUT74876A (es) |
NO (1) | NO313813B1 (es) |
NZ (1) | NZ279820A (es) |
PT (1) | PT744944E (es) |
RU (1) | RU2154455C2 (es) |
WO (1) | WO1995022322A1 (es) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19635883A1 (de) * | 1996-09-04 | 1998-03-05 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
GB9720470D0 (en) | 1997-09-25 | 1997-11-26 | Ethical Pharmaceuticals South | Inhibition of crystallization in transdermal devices |
FR2774595A1 (fr) * | 1998-02-06 | 1999-08-13 | Rech D Innovation Et De Dev Ce | Emulsion pour l'administration transdermique de steroides |
DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
DE19828273B4 (de) * | 1998-06-25 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren |
EP1061900B2 (en) * | 1999-01-14 | 2008-07-09 | Noven Pharmaceuticals, Inc. | Dermal compositions |
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
US6846496B1 (en) * | 1999-10-15 | 2005-01-25 | Orion Corporation | Treatment of osteoporosis |
US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
US20020004065A1 (en) | 2000-01-20 | 2002-01-10 | David Kanios | Compositions and methods to effect the release profile in the transdermal administration of active agents |
DE10025971B4 (de) * | 2000-05-25 | 2004-09-02 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
AR030312A1 (es) | 2000-08-03 | 2003-08-20 | Antares Pharma Ipl Ag | Composicion novedosa para la administracion transdermica y/o transmucosica de compuestos activos, que asegura adecuados niveles terapeuticos |
EP1216699A1 (de) * | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
SE0102152L (sv) * | 2001-06-18 | 2002-12-19 | Sca Hygiene Prod Ab | Ny produkt |
DE10211832A1 (de) * | 2002-03-16 | 2003-10-02 | Lohmann Therapie Syst Lts | Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion |
RS50428B (sr) | 2003-02-21 | 2009-12-31 | Bayer Schering Pharma Aktiengesellschaft, | Uv-stabilni transdermalni flasteri |
US20050042182A1 (en) * | 2003-08-13 | 2005-02-24 | Moshe Arkin | Topical compositions of urea |
US20050037040A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of urea and ammonium lactate |
US20050036953A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of ammonium lactate |
US20050025833A1 (en) * | 2003-07-16 | 2005-02-03 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
US20050042268A1 (en) * | 2003-07-16 | 2005-02-24 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
NZ546106A (en) | 2003-10-10 | 2008-10-31 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
EP1682061B1 (en) * | 2003-10-28 | 2017-03-15 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device |
UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
KR101168449B1 (ko) * | 2003-12-12 | 2012-07-25 | 바이엘 파마 악티엔게젤샤프트 | 침투 증진인자가 필요없는 호르몬의 경피 전달계 |
US9205062B2 (en) * | 2004-03-09 | 2015-12-08 | Mylan Pharmaceuticals, Inc. | Transdermal systems containing multilayer adhesive matrices to modify drug delivery |
GB0409498D0 (en) * | 2004-04-28 | 2004-06-02 | Hunter Fleming Ltd | Transdermal steroid formulation |
US7425340B2 (en) * | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
US20080171687A1 (en) * | 2004-09-16 | 2008-07-17 | Abraxis Bioscience, Inc. | Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
US8343538B2 (en) | 2004-10-08 | 2013-01-01 | Noven Pharmaceuticals, Inc. | Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems |
US20060078602A1 (en) | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Device for transdermal administration of drugs including acrylic polymers |
WO2007124250A2 (en) * | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
WO2006125642A1 (en) * | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
WO2008136699A1 (fr) * | 2007-05-04 | 2008-11-13 | Igor Alexandrovich Bazikov | Patch transdermique à microcapsules et procédé de fabrication correspondant |
ES2574933T3 (es) | 2007-11-13 | 2016-06-23 | Athenion Ag | Esteroides de C-19 para usos cosméticos |
PL2949361T3 (pl) | 2007-11-13 | 2017-09-29 | Athenion Ag | Steroidy C-19 do leczenia celulitu |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
LT2419108T (lt) | 2009-04-14 | 2016-12-27 | Laboratoire Hra Pharma | Kontracepcijos pagal poreikį būdas |
ES2574999T3 (es) | 2009-04-14 | 2016-06-23 | Laboratoire Hra-Pharma | Método para la contracepción a demanda usando levonorgestrel o norgestrel |
AR077490A1 (es) * | 2009-07-21 | 2011-08-31 | Novartis Ag | Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel |
GB0919210D0 (en) * | 2009-11-03 | 2009-12-16 | Syntopix Ltd | Formulations |
US8563031B2 (en) * | 2010-05-27 | 2013-10-22 | Absize, Inc. | Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith |
DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
RS55681B1 (sr) | 2010-09-06 | 2017-07-31 | Bayer Ip Gmbh | Transdermalni flasteri sa malom dozom i velikim oslobađanjem leka |
JP6152092B2 (ja) * | 2011-05-15 | 2017-06-28 | エーセラス ファーマシューティカルズ コーポレーション | 経鼻投与のための徐放テストステロン鼻腔内ゲル、方法および複数回用量プレフィルアプリケーターシステム |
PT3172964T (pt) * | 2011-09-12 | 2020-11-30 | Boehringer Ingelheim Animal Health Usa Inc | Composições parasiticidas compreendendo um agente ativo de isoxazolina, método e utilizações das mesmas |
EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2014281317A1 (en) * | 2013-06-20 | 2016-02-04 | Mylan Technologies, Inc. | Storage stable transdermal patch of rotigotine |
JP2017516768A (ja) | 2014-05-22 | 2017-06-22 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然の併用ホルモン補充療法剤及び療法 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
RU2705896C1 (ru) * | 2019-07-26 | 2019-11-12 | Артем Олегович Бахметьев | Трансдермальный пластырь |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4082881A (en) * | 1976-12-23 | 1978-04-04 | E. R. Squibb & Sons, Inc. | Topical and other type pharmaceutical formulations containing isosorbide carrier |
DE3333240A1 (de) * | 1983-09-12 | 1985-03-28 | Schering AG, 1000 Berlin und 4709 Bergkamen | Mittel zur transdermalen applikation von arzneimittelwirkstoffen |
DE3714140A1 (de) * | 1987-04-28 | 1988-11-10 | Lohmann Therapie Syst Lts | Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut |
US5538736A (en) * | 1987-04-28 | 1996-07-23 | Lts Lohmann Therapie-Systeme Gmbh | Active substance-containing plaster for the controlled administration of active substances to the skin |
IT1223343B (it) * | 1987-11-03 | 1990-09-19 | Also Lab Sas | Formulazioni farmaceutiche per somministrazione transdermica |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
ATE99939T1 (de) * | 1990-06-14 | 1994-01-15 | Henning Berlin Gmbh | Fluessig befuellte steckkapselpraeparate. |
-
1994
- 1994-02-18 DE DE4405898A patent/DE4405898A1/de not_active Withdrawn
-
1995
- 1995-02-09 WO PCT/EP1995/000483 patent/WO1995022322A1/de active IP Right Grant
- 1995-02-09 AU AU17066/95A patent/AU1706695A/en not_active Abandoned
- 1995-02-09 DE DE59507188T patent/DE59507188D1/de not_active Expired - Fee Related
- 1995-02-09 EP EP95908925A patent/EP0744944B1/de not_active Expired - Lifetime
- 1995-02-09 JP JP7521561A patent/JPH09508912A/ja active Pending
- 1995-02-09 CA CA002183543A patent/CA2183543C/en not_active Expired - Fee Related
- 1995-02-09 ES ES95908925T patent/ES2140658T3/es not_active Expired - Lifetime
- 1995-02-09 AT AT95908925T patent/ATE186213T1/de not_active IP Right Cessation
- 1995-02-09 US US08/693,050 patent/US5904931A/en not_active Expired - Fee Related
- 1995-02-09 RU RU96118462/14A patent/RU2154455C2/ru not_active IP Right Cessation
- 1995-02-09 DK DK95908925T patent/DK0744944T3/da active
- 1995-02-09 KR KR1019960704501A patent/KR100392435B1/ko not_active IP Right Cessation
- 1995-02-09 NZ NZ279820A patent/NZ279820A/en not_active IP Right Cessation
- 1995-02-09 PT PT95908925T patent/PT744944E/pt unknown
- 1995-02-09 HU HU9602283A patent/HUT74876A/hu unknown
-
1996
- 1996-08-19 NO NO19963447A patent/NO313813B1/no not_active IP Right Cessation
-
2000
- 2000-01-28 GR GR20000400206T patent/GR3032512T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU1706695A (en) | 1995-09-04 |
CA2183543A1 (en) | 1995-08-24 |
NO313813B1 (no) | 2002-12-09 |
RU2154455C2 (ru) | 2000-08-20 |
HU9602283D0 (en) | 1996-10-28 |
NO963447L (no) | 1996-08-19 |
KR970701039A (ko) | 1997-03-17 |
DK0744944T3 (da) | 2000-04-25 |
HUT74876A (en) | 1997-02-28 |
WO1995022322A1 (de) | 1995-08-24 |
ATE186213T1 (de) | 1999-11-15 |
DE59507188D1 (de) | 1999-12-09 |
KR100392435B1 (ko) | 2003-11-28 |
JPH09508912A (ja) | 1997-09-09 |
CA2183543C (en) | 2009-07-14 |
EP0744944A1 (de) | 1996-12-04 |
GR3032512T3 (en) | 2000-05-31 |
DE4405898A1 (de) | 1995-08-24 |
NZ279820A (en) | 1998-08-26 |
US5904931A (en) | 1999-05-18 |
PT744944E (pt) | 2000-04-28 |
EP0744944B1 (de) | 1999-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2140658T3 (es) | Sistemas terapeuticos transdermicos que contienen esteroides sexuales. | |
FI956014A0 (fi) | Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon | |
NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
DE59508891D1 (de) | Hautpflegemittel | |
ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
ES2130446T3 (es) | Sistema terapeutico transdermico que contiene octildodecanol como inhibidor de cristalizacion. | |
NO980317L (no) | Anvendelse av Calendula-glykosider for behandling av psoriasis | |
DE69102704D1 (de) | Orales, melatonin enthaltendes arzneimittel. | |
IL139318A0 (en) | Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same | |
FI962550A0 (fi) | Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa | |
DE69120287T2 (de) | Aminosulfonylharnstoff-acat-inhibitoren | |
TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
HUP0204208A2 (hu) | Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény | |
NO960525L (no) | Terapeutisk preparat | |
GB9227123D0 (en) | Method | |
DK0663832T3 (da) | Anvendelse af 4'-iod-4'-deoxydoxorubicin til behandling af amyloidose | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
NO307204B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader | |
ES2159479A1 (es) | Nuevos indazoles como inhibidores de la ciclooxigenasa-ii | |
GEP20002177B (en) | Ointment “Levaskani” for Treatment of Wounds and Burns | |
UA23046C2 (uk) | Протимікробhий засіб |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 744944 Country of ref document: ES |